Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in Colgate-Palmolive (NYSE:CL - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 1,077,440 shares of the company's stock, valued at approximately $97,950,000. Universal Beteiligungs und Servicegesellschaft mbH owned 0.13% of Colgate-Palmolive as of its most recent SEC filing.
Other institutional investors also recently added to or reduced their stakes in the company. Barclays PLC lifted its position in shares of Colgate-Palmolive by 38.7% during the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company's stock valued at $793,542,000 after acquiring an additional 2,132,747 shares during the period. Brighton Jones LLC increased its stake in Colgate-Palmolive by 4.4% in the 4th quarter. Brighton Jones LLC now owns 10,578 shares of the company's stock valued at $962,000 after purchasing an additional 450 shares in the last quarter. Jamison Private Wealth Management Inc. raised its holdings in Colgate-Palmolive by 531.7% during the fourth quarter. Jamison Private Wealth Management Inc. now owns 3,670 shares of the company's stock worth $334,000 after purchasing an additional 3,089 shares during the last quarter. Drive Wealth Management LLC boosted its position in Colgate-Palmolive by 23.9% during the fourth quarter. Drive Wealth Management LLC now owns 3,014 shares of the company's stock worth $274,000 after purchasing an additional 582 shares in the last quarter. Finally, Stonehage Fleming Financial Services Holdings Ltd increased its position in shares of Colgate-Palmolive by 11.4% in the fourth quarter. Stonehage Fleming Financial Services Holdings Ltd now owns 1,086,752 shares of the company's stock valued at $98,797,000 after buying an additional 110,788 shares in the last quarter. Hedge funds and other institutional investors own 80.41% of the company's stock.
Colgate-Palmolive Trading Up 0.8%
Colgate-Palmolive stock traded up $0.72 during trading on Friday, reaching $93.02. The company had a trading volume of 6,317,272 shares, compared to its average volume of 4,706,422. Colgate-Palmolive has a 12-month low of $85.32 and a 12-month high of $109.30. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92. The stock's 50 day moving average price is $92.02 and its two-hundred day moving average price is $91.27. The firm has a market capitalization of $75.39 billion, a price-to-earnings ratio of 26.43, a PEG ratio of 4.20 and a beta of 0.39.
Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its quarterly earnings data on Friday, April 25th. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.86 by $0.05. The company had revenue of $4.91 billion during the quarter, compared to analysts' expectations of $4.92 billion. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. The business's quarterly revenue was down 3.0% compared to the same quarter last year. During the same period in the previous year, the company earned $0.86 EPS. As a group, equities analysts expect that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.
Colgate-Palmolive declared that its Board of Directors has authorized a share repurchase plan on Thursday, March 20th that allows the company to buyback $5.00 billion in outstanding shares. This buyback authorization allows the company to purchase up to 6.8% of its shares through open market purchases. Shares buyback plans are usually an indication that the company's leadership believes its stock is undervalued.
Colgate-Palmolive Increases Dividend
The company also recently announced a quarterly dividend, which was paid on Thursday, May 15th. Stockholders of record on Thursday, April 17th were issued a dividend of $0.52 per share. The ex-dividend date was Thursday, April 17th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.24%. This is a boost from Colgate-Palmolive's previous quarterly dividend of $0.50. Colgate-Palmolive's payout ratio is presently 58.76%.
Analysts Set New Price Targets
Several equities research analysts recently commented on CL shares. UBS Group boosted their price objective on shares of Colgate-Palmolive from $105.00 to $109.00 and gave the stock a "buy" rating in a research report on Thursday, April 17th. Piper Sandler lowered their price target on shares of Colgate-Palmolive from $108.00 to $107.00 and set an "overweight" rating on the stock in a research report on Monday, March 31st. Wells Fargo & Company raised their price objective on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the stock an "underweight" rating in a research note on Wednesday, April 2nd. Citigroup upped their target price on Colgate-Palmolive from $103.00 to $108.00 and gave the company a "buy" rating in a research note on Monday, April 28th. Finally, Stifel Nicolaus dropped their price target on Colgate-Palmolive from $95.00 to $93.00 and set a "hold" rating for the company in a research report on Monday, February 3rd. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and ten have issued a buy rating to the company. According to data from MarketBeat, Colgate-Palmolive has a consensus rating of "Hold" and a consensus target price of $102.12.
View Our Latest Stock Report on Colgate-Palmolive
About Colgate-Palmolive
(
Free Report)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
See Also

Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.